| INOVIO PHARMACEUTICAL INC |
| USA |
| Gesundheit |
| US45773H4092 / A400EJ |
| GBM (Frankfurt) / INO (NASDAQ) |
| FRA:GBM, ETR:GBM, GBM:GR, NASDAQ:INO |
| - |
| https://inovio.com/ |
|
Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing DNA medicines for treating and protecting against HPV-related diseases, cancer, and infectious diseases. The company employs proprietar..
>Volltext.. |
| 79.68 Mio. EUR |
| 54.5 Mio. EUR |
| - |
| -70.44 Mio. EUR |
| -74.11 Mio. EUR |
| -1.49 EUR |
| 7.59 Mio. EUR |
| 22.92 Mio. EUR |
| -72.72 Mio. EUR |
| 0.99 |
| -100% |
| 17.57% |
| - |
| - |
| - |
| - |
| INOVIO |
| 19.06.26 |
|